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Abstract
Background: Cancer health disparities affecting low-income and minority patients are well documented. Root-
causes are multifactorial, including diagnostic and treatment delays, social and financial barriers, and poor
communication. Patient navigation and communication coaching (activation) are potential interventions to address
disparities in cancer treatment. The purpose of this clinical trial is to test the effectiveness of an intervention
combining patient navigation and activation to improve cancer treatment.
Methods/Design: The Rochester Patient Navigation Research Program (PNRP) is a National Cancer Institute-
sponsored, patient-level randomized trial (RCT) of patient navigation and activation, targeting newly-diagnosed
breast and colorectal cancer patients in Rochester, NY. The goal of the program is to decrease cancer health
disparities by addressing barriers to receipt of cancer care and promoting patient self-efficacy. The intervention
uses trained, paraprofessional patient navigators recruited from the target community, and a detailed training and
supervisory program. Recruited patients are randomly assigned to receive either usual care (except for baseline and
follow-up questionnaires and interviews) or intervention. The intervention patients receive tailored assistance from
their patient navigators, including phone calls, in-person meetings, and behind-the-scenes coordination of care.
A total of 344 patients have been recruited. Outcomes measured at three month intervals include timeliness of
care, patient adherence, patient satisfaction, quality of life, self-efficacy, health literacy, and cancer knowledge.
Discussion: This unique intervention combining patient navigation and patient activation is designed to address
the multifactorial problem of cancer health disparities. If successful, this study will affect the design and
implementation of patient navigation programs.
Trials Registration: clinicaltrials.gov identifier NCT00496678.
Background
Like the larger health care system in the United States
(US), cancer care is fragmented, poorly coordinated and
often not organized around the needs of the patient[1].
Many patients leave their health care visit confused
about their diagnosis, prognosis, options for treatment,
and next steps[2,3]. These problems are particularly
severe for members of socially disadvantaged groups,
including minority, low income, uninsured, non-English-
speaking and low health literacy patients, and contribute
to significantly higher cancer mortality rates[4].
Healthcare disparities based on social disadvantage,
including race, ethnicity, socioeconomic status, language,
and insurance, have been well documented for cancer
screening[5], follow-up of abnormal cancer test results
[6,7], and cancer treatment[7,8], [9]. The causes for dis-
parities are multifactorial, including patient characteris-
tics such as low health literacy, patient access barriers
such as lack of healthcare insurance, provider factors
such as cultural competency, and practice organizational
factors such as a lack of systems to track patients at risk
(Figure 1). In addition, interactions between factors may
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clinician-patient communication[10-12]. Studies in
which equal treatment is meticulously provided to
patients, irrespective of race, ethnicity, and socio-demo-
graphic backgrounds, have shown a significant reduction
in disparities in treatment outcome for patients with
breast and colorectal cancer,[13-15] indicating the
potential to decrease cancer health disparities.
Two different models to address these problems have
emerged in recent years: patient navigation (PN) and
patient activation (PA) often referred to as “patient
empowerment”. We briefly review the history of each,
discuss a conceptual framework for integration of the
two into the same model, and conclude with our experi-
ence in implementing the integrated model in the set-
ting of an ongoing randomized controlled trial.
Conceptual Framework for Navigation-Activation
Because the causes of cancer health disparities are
multi-factorial, an optimal intervention to address dispa-
rities must address different dimensions of the problem.
The navigation-activation program combines PN and
PA to improve patient-physician communication. These
components are described briefly and the combined pro-
gram is diagrammatically presented.
Patient Navigation
For more than 40 years, community health workers
(CHW’s) have enhanced access to care among under-
served populations in the United States (US)[16,17].
Freeman et al reported that 87% of inner-city patients
with abnormal cancer findings who received PN from
CHW’s completed recommended biopsies compared to
only 57% among those who were not navigated[18].
More recently, CHW’s have been shown to improve
outcomes in prenatal care[19], smoking cessation[20],
child[21] and adult immunizations[22], and diabetes and
depression management[23].
Patient navigation programs for cancer-related care
have been developed across the US, including more
than 100 PN programs sponsored by the American Can-
cer Society. Most PN programs share a number of
Figure 1 Theoretical Model Linking Patient, Provider and Health System Factors to Cancer Health Disparities[41]. (*indicates factor
measured in the present study)
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abnormal cancer screening or diagnostic tests by identi-
fying and addressing barriers to quality and timely
health care. For example, PN’s may help patients keep
track of appointments, interpret medical information,
and provide social support[24].
Patient Activation
Randomized controlled trials have demonstrated that
interventions to train patients to assume more active
involvement in their care and to ask more appropriate
and relevant questions (“activation”) can improve
patients’ outcomes[25,26]. Activation improves patient
satisfaction with care and physician counseling[27,28],
and adherence to treatment and follow-up appointments
[29]. Pre-visit planning and coaching of breast cancer
patients improves both patient and physician visit satis-
faction[30]. Patient question-asking and provision of
clear information by clinicians is associated with fewer
diagnostic delays among black women with abnormal
mammograms[12]. Patient assertiveness may attenuate
racial and socioeconomic disparities in breast cancer
evaluation[31]. These findings suggest that “activating”
patients may be one means of improving cancer care for
disadvantaged patients. However, not all such studies
have positive results, and the specific techniques and
settings of activation interventions are probably impor-
tant to achieving desired results[32,28].
In prior studies, “activation” has been conceptualized
as an intervention of limited duration, intended to pro-
vide education and empowerment. Conversely, PN has
been structured as an ongoing, longer-term relation-
ship between the patient and the navigator that pro-
vides a variety of supports. Navigation-activation
brings activation together with PN as a longitudinal
intervention. How can this intervention potentially
decrease health disparities and improve health out-
comes? Figure 1 provides a theoretical model to
explain how this intervention may improve outcomes
by affecting factors that mediate cancer health dispari-
ties. Disparities in care related to social disadvantage
are mediated through patient access barriers, provider
factors, and practice organizational factors. By poten-
tially reducing delays in patient care and improving
patient adherence and quality of care, patient naviga-
tion-activation seeks to improve quality of life, satisfac-
tion, and survival.
Cancer Health Communication
Effective communication between patients and health-
care providers is critically important for optimal care
[33]. Poor communication may undermine patients’ abil-
ity to understand their treatment options, cope with
anxiety caused by cancer, make informed decisions
regarding diagnostic and therapeutic procedures[34-36],
and adhere to treatment[37].
The navigation-activation model is consistent with a
recently-proposed conceptual framework for developing
evidence-based interventions to improve health care
communication[38,39]. A recent National Cancer Insti-
tute report on patient-centered communication suggests
pathways by which effective communication is linked to
high-quality medical decisions, adherence, patient and
clinician satisfaction and improved health[38,40]. Navi-
gators directly address patient self-management,o n eo f
the essential functions of communication. Through
forming strong therapeutic relationships and providing
both emotional and instrumental support, navigators
assist patients in information exchange with providers,
as well as other essential communication functions.
Navigators can help patients forge a more participa-
tory dialogue with their clinicians. Specifically, naviga-
tors help patients ask clinicians questions that lead to a
clearer understanding of their illness and treatment.
They also coach patients to better inform clinicians
about their experiences and preferences. Through this
improved dialogue, patien t sc o m et op o s s e sb o t ht h e
information and support to participate effectively in
decisions regarding their health.
Methods/Design
Study Design
The University of Rochester Patient Navigation Research
Program (UR-PNRP) is a National Cancer Institute-
funded, 5-year, randomized trial of PN for patients with
a new diagnosis of breast or colorectal cancer, or with a
positive screening test for these diseases[41]. The pri-
mary outcomes of the UR-PNRP are timeliness of care,
guideline-concordant care, patient satisfaction, and qual-
ity of life.
Selection of Study Sites
All oncology practices in the city of Rochester were
recruited to participate in the PNRP program, as well as
several primary care practices in Rochester, and several
oncology practices in the surrounding community.
Patient eligibility, recruitment, consent and
randomization
Patients eligible for participation in the PNRP study are
newly-diagnosed breast and colorectal cancer patients
from participating practices, and patients with a positive
screening test for these diseases. There are no exclusion
criteria based upon socioeconomic status, race or insur-
ance, but institutionalized patients and those with
dementia or prior cancer (other than non-melanoma
skin cancer) are excluded. Figure 2 is a flow chart of
patient enrollment, randomization and progress through
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the Institutional Review Boards of the University of
Rochester and participating sites in the area. All patients
participating in the study provide written informed
consent.
Data Collection
Patient information is collected by research assistants
prior to randomization. Patient demographic informa-
tion is obtained from medical records and patient self-
report, via in-person interview. Outcome measures are
collected for both intervention and control patients at
baseline and at three month intervals, as detailed in
Table 1. In addition, information on barriers to care was
collected by patient navigators, in the intervention
group only, during semi-structured interviews with
patients. A standardized form was used. Navigators also
keep detailed records of their activities performed on
behalf of their caseload of navigated patients, and the
time each activity took.
Recruiting and Training Patient Navigators
Non-medically-trained persons from the community
were recruited to be PN’s. Minimal selection criteria
included a high school degree[42], reliable mode of
transportation and a current driver’s license. Preference
Figure 2 Diagram of Patient Flow through the Clinical Trial.
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ment. Desirable personal qualities included strong inter-
personal and communication skills, fluency in Spanish
and English, ability to learn, dependability, initiative, and
passion and commitment to improving health care for
underserved patients.
The Navigator Curriculum
The first navigators received a six-month, intensive
training program that covered the basics of cancer diag-
nosis and treatment and each of the PN tasks, as out-
lined in Table 2. Subsequently, the training has been
shortened to less than half this time. All navigators also
completed an 80-hour core curriculum (The Cornell
Project) developed by New York State for the training of
CHW’s and yearly two to three day national training
seminars, sponsored by the American Cancer Society.
Project investigators, other medical professionals, local
government resources, and local private agencies were
recruited to participate in the training program. Train-
ing in patient activation involves a series of observed
and evaluated interactions with trained, standardized
cancer patients (actors trained to portray patients).
A navigator manual was created, including standard
operating procedures, lists of community resources and
patient educational materials, as well as materials to
reinforce the training curriculum.
All of the navigators completed the training program
prior to working with patients. The success of navigator
training was evaluated in several ways. The core CHW
curriculum (The Cornell Project) required post-testing
to obtain certification. In addition, PN’s were regularly
observed by their supervisor during patient encounters.
Encounter forms were checked for accuracy and consis-
tency. Computer skills were supervised to ensure mini-
mal standards were met. Passing scores on tests for
research ethics certification and patient confidentiality
were required. PN’s were also pre- and post-tested at
national training sessions.
Characteristics of Navigators
The first three PN’s recruited were females: one African-
American and two Puerto Rican-Americans who were
fluent in Spanish. Over time, three additional Navigators
have been hired and trained, including two African-
American females and one white male. None of the
Table 1 Outcome and Other Measures of the Patient Navigation Research Program
Category Title Collection Times (mo)
Primary Outcome Measures
Time to completion of Treatment Time to completion of Treatment
Satisfaction Patient Satisfaction with Care 0;3;6;9;12
Cost Cost
Knowledge/Health Literacy
Health literacy Rapid Estimate of Adult Literacy in Medicine (REALM) 0
Knowledge Breast Cancer Treatment Knowledge 0;3;FU
Knowledge Colorectal Cancer Treatment Knowledge 0;3;FU
Quality of Life
Quality of Life Impact of Events Scale (IES) 0;3;6;9;12
Cancer Related Health Status Functional Assessment of Cancer Therapy-Breast Cancer (FACT-B) 0;3;6;9;12
Cancer Related Health Status Functional Assessment of Cancer Therapy-Colorectal Cancer (FACT-C) 0;3;6;9;12
Medical Conditions Charlson Commorbidity chart review
Adherence
Adherence Medical Outcomes Study (MOS) General Adherence Items 0;3;6;9;12
Beliefs Beliefs about Medication Questionnaire (BMQ) 0;3;6;9;12
Interaction
Attachment Style Relationship Questionnaire (Attachment Style) 0
Intensity Navigator Perceived Time and Emotional Intensity of Patient Navigation 0;3;6;9;12
Self Efficacy The Communication and Attitudinal Self-Efficacy Scale (CASE) 0;3;6;9;12
Satisfaction Patient Satisfaction with Navigator 3; FU
Tracking Patient Navigator Tracking Logs - encounter times, barriers, and actions Throughout
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had previous experience with health insurance enroll-
ment, being a patient in the medical system, and/or pre-
vious community work experience.
Supervision for Navigators
N a v i g a t o r sa r es u p e r v i s e db yam a s t e r ’s level social
worker with experience in clinical supervision, teaching,
research, and work in primary care. The navigator
supervisor provides real-time consultation and supervi-
sion of case management, through weekly meetings with
each of the navigators, cell phone contact, review of
documentation, and review of selected audiotapes (with
patients’ consent) of meetings between navigators and
patients. Supervision also includes professional support
of the PN’s, recognizing the emotionally intense work
they are doing and promoting self-care to minimize
“burnout”. Quarterly, each PN is directly observed by
the supervisor in patient interactions to ensure that
basic competencies continue to be met.
Description of the Navigation Intervention
After enrollment and completion of baseline data collec-
tion, patients are randomly assigned to standard care or
patient navigation-activation. Patients assigned to navi-
gation are contacted within three days by their PN to
assess their needs. PN’s conduct a semi-structured
assessment interview in-person or over the phone to
identify barriers to care. Table 3 lists the types of bar-
riers that PN’s were trained to address. Navigators also
immediately become involved in performing proactive
services on the patient’s behalf, such as appointment
reminders, in order to prevent delays in receiving treat-
ment or follow-up care with their medical provider.
Table 2 Navigator Training Program
Training Activity Concepts Educator(s)
In-House Training
Cancer Health Disparities
Overview
Patient, provider, practice and health system barriers to care Program director
Research 101 Human subject protection, HIPAA
a Project coordinator
Standard Operating
Procedures and Case
Management
Project coordinator, PN supervisor
Orientation to Participating
Health Care Settings
Visit practices; computer medical database training Project coordinator, PN supervisor
Cancer 101 Physicians teach PN’s basics of cancer diagnosis and treatment; shadowing
MD’s at patient office visits, colonoscopies; observing tumor board
conference at cancer center; visit to pathology laboratory
Medical oncologist, surgical oncologist
Interpersonal
Communication 101
“How to talk to your doctor”,
“Patient empowerment”, others
PN Supervisor; communications
researcher; staff of non-profit agency
Computer Literacy Email; Microsoft office; computerized calendars; internet searches for
resources and patient care guidelines
Project coordinator, research assistants
Domestic Violence Child protective services and domestic violence lectures Department of Health and Human
Services
Community Resources Transportation, financial counseling, interpreter services, child care, social
work
Social worker from cancer center
Motivational Interviewing Self-determination and empowerment Research assistant
End of Life Care Transition from treatment to palliation Hospice nurse
Personal Safety Actions to minimize risk Police department
The Health System Review of government and private health insurances PN supervisor
The Initial Assessment
Interview
A semi-structured interview was designed, and PN’s learned to conduct it,
using the skills of “joining”, history-taking, assessment of patient barriers, and
making follow-up plans
PN supervisor
External Training
Cornell Empowering
Families Project
New York State program for CHWs. Topics include: relationship and
communication skills; cultural competence; working with low-literacy
patients; needs assessment; empowerment; CHW self-care
The Cornell Project
Simulated Patient Training Simulated patients, with video-taping and feedback Local, private agency that provides
standardized patients for medical
training
NCI/ACS
a Navigator Training
Summit
4 day program with navigators from across the US
aHIPAA = Health Insurance Portability and Accountability Act; NCI = National Cancer Institute; ACS = American Cancer Society.
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uses a variety of strategies to address the barriers.
Actions taken by the PN include: supportive contact
with the patient, such as face-to-face meetings, tele-
phone, email or regular mail correspondence; identifying
and linking patients to social or financial resources and
appropriate community supports; helping with paper-
work, obtaining records, scheduling appointments, fol-
lowing-up on test scheduling or results; and
accompanying the patient to appointments to help
coach as well as providing emotional support.
Navigators provide patients with approved educational
materials and promote treatment adherence. Navigators
facilitate coordination of care by ensuring that consulta-
tion reports, test results, and new prescriptions or pre-
scribed treatments are available to all providers at the
time of an appointment. Navigators notify providers
when a patient misses an appointment or treatment or
experiences new or changed symptoms. Navigators are
specifically trained to effectively interact with profes-
sional health care personnel.
For patient activation, PN’s offer all patients coaching
in communication skills. Navigators meet with patients
prior to appointments and assist patients in identifying
one to three concerns they wish to address during their
visit, and create question lists as tools for patients to
use during visits. Patients rehearse how to ask questions,
follow-up when they are unclear about the response
they receive, and re-state the plan to confirm under-
standing. Though often present during visits, PN’s
encourage patients to assume an active role during vis-
its, rather than speaking for them. Navigators debrief
with patients following the medical visits, to identify and
clarify potential areas of confusion.
Tailored Intensity of Navigation
Participating patients receive navigation of differing
intensity depending on their access barriers, needs, and
resources. Patients who report few or no access barriers
and report no need for navigation services receive low-
intensity navigation. For example, a woman with an
abnormal mammogram who requires no assistance and
does not desire coaching in communication receives
support and reminder phone calls only. High intensity
navigation is indicated for a patient with cancer who
faces access barriers to care or who experiences signifi-
cant complications from treatment requiring intensive
coordination of care among providers.
In summary, the navigation-activation intervention is
designed to identify barriers, assist patients in overcom-
ing them, provide emotional support, improve patient
understanding of his or her condition and treatment,
empower the patient to become actively involved in his
or her care, improve adherence to treatment, and pro-
mote patient satisfaction with health care. Thus, the
intensity of navigation is tailored to the needs of the
patient.
Patient Accrual and Study Flow
The clinical trial began in 2005 with a planning and
development phase followed by recruitment of three
CHW navigators and a supervisor in 2006. Three hun-
dred forty-four patients have been recruited into the
program, and 178 were randomly assigned to the navi-
gation-activation intervention group, following informed
consent. In addition to the planned assessments, semi-
structured exit interviews are also being conducted with
all subjects as they complete the program to assess their
cancer-treatment experiences and their experiences with
the navigators, for quality control.
Table 3 The Navigation-Activation Intervention
Phase 1: Patient
Intake
Identify Barriers to Quality Care
Transportation
Housing
Insurance
Literacy
Language
Child Care/elder care
Family/Community Supports
Geographic Distance from Health Care
Adequate Health Insurance
Financial Problems
Work Schedule
Medical Communication Concerns
Fear
Comorbid Illnesses
Disability
Perceptions/Beliefs about Treatment
Systems Problems with Scheduling Care
Attitudes toward Providers
Other
Phase 2: Patient
Navigation-
Activation
Address Barriers
Provide Information
Provide Pre-Appointment Coaching
Provide Emotional and Social Support
Provide Appointment Reminders
Link to Resources
Phase 3:
Assessment of
Intervention
Outcomes
Time to Completion of Treatment
Treatment Guideline-Compliant Care
Patient Satisfaction
Patient Knowledge and Self-Efficacy
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common barriers identified and addressed by the patient
navigators include financial difficulties, lack of health
insurance, lack of social support, lack of transportation,
difficulty communicating with health care providers, and
limited English proficiency. In addition to planned help
provided by our navigators to address these barriers,
navigators also help patients organize and follow-
through with doctors’ appointments, and helping them
understand medical information.
Planned Analytic Approach
The primary outcome measures for this clinical trial
include time to completion of treatment (or to diagnos-
tic resolution in the case of patients with positive
screening tests), patient satisfaction, and cost. Details
regarding each of these measures are as follows:
Time to completion of cancer treatment
This measure is defined based on review of medical
records following completion of treatment for oncology
subjects. It will be assessed based on time (in days) from
the date of the initial oncology/surgical consultation to
completion of cancer treatment (e.g. surgery, che-
motherapy regimen, or radiation, whichever occurs last).
Health care satisfaction
We hypothesize improvements in satisfaction with
health care. Baseline satisfaction is measured using a
newly created patient satisfaction with cancer care (con-
tinuous measure). It is assessed at baseline for all sub-
jects and at three months for primary care subjects and
at three months, six, nine and twelve months for sub-
jects with cancer or at the end of treatment.
Costs of navigation
We assess the costs of navigation including supervision.
We assess the costs of navigator time by asking naviga-
tors to track their time spent on navigaton-related func-
tions. These include training time and in-services,
meetings with supervision, e n t r yo fd a t af o rs u b j e c t s
assigned to navigation, phone calls related to navigation,
meetings with subjects and families, meetings and phone
calls with providers and office staff, and travel time. The
proportion of time devoted to navigation will be multi-
plied by navigator cost (salary plus benefits). Additional
expenses include costs for supervision, transportation,
child care, and patient educational materials. Patient
navigator supervision time will be based on the percent
of time related to navigation. We also collect data (e.g.
medical records) needed to estimate the health care costs
of subjects assigned to either navigation or usual care.
Subjects are also asked to estimate time (nearest day)
that they missed work to visits or disability.
Secondary outcome measures for this study are guide-
line concordant care, patient adherence, health literacy,
patient activation, medical knowledge, and functional
health status. Details regarding analysis of these out-
comes include:
Guideline concordant cancer care
This is a dichotomous measure, defined as concordance
(yes/no) between diagnostic and therapeutic manage-
ment documented in the medical records, and national
guidelines for evaluation and treatment of breast or col-
orectal cancer according to stage, age, and hormone
receptor status. An oncologist (JG) will assess guideline
concordant care by reviewing abstracted data, and will
be blinded to group assignment. Depending on the find-
ings, use of an ordinal measure will also be considered.
Patient adherence to recommendations
We will measure patient adherence from both chart
abstraction and patient report. Patient adherence to
diagnostic recommendations is based on the percentage
of missed appointments for diagnostic testing. Subject
adherence to treatment is assessed based on the percent
of recommended courses of radiation received or per-
centage of full chemotherapy received and percentage of
cancer visits that are missed. We also are measuring
relative dose intensity (RDI) for breast cancer patients
who receive chemotherapy. RDI is a standard measure
of optimal chemotherapy dosing. Dose intensity is
amount of drug delivered per unit time typically stan-
dardized to body surface area as mg/m
2/week. The RDI
is the ratio of the dose intensity actually received rela-
tive to optimal dose intensity.
Health literacy
We hypothesize that persons with low health literacy
will derive more benefit from navigation than those with
higher literacy. The Rapid Estimate of Adult Literacy in
Medicine (REALM) for English speakers and the Short
Assessment of Health Literacy for Spanish Adults
(SAHLSA) will be used to assess health literacy among
all subjects at baseline. Less than seventh grade reading
level will be considered low-literacy. Secondary analyses
will examine health literacy as a continuous variable.
This measure is omitted among the few subjects who do
not speak English or Spanish.
Self-Efficacy
We assess patient self-efficacy among all subjects using
the Communication and Attitudinal Self-Efficacy Scale
for cancer (CASE)[43]. CASE scores are assessed at
baseline, three months, six months, and twelve months
for subjects with cancer.
Knowledge
We anticipate that navigation will be associated with
improvements in knowledge. We will assess knowledge
about breast cancer and colorectal cancer and its treat-
ment using instruments developed by our investigators.
It will be assessed at baseline for all subjects and at
three months for primary care subjects and at six and
twelve months for subjects with cancer.
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We will assess overall quality of life using the Functional
Assessment of Cancer Therapy[44] scales (FACT-C and
FACT-B). These will be assessed at baseline among all
subjects, at three months among primary care subjects
a n da ts i xa n dt w e l v em o n t h sa m o n gs u b j e c t sw i t h
cancer.
Sample Size Determination
Sample size calculations were calculated for time to
completion of treatment for diagnosed cancer patients,
specifically to assess differences between the interven-
tion and control groups in the proportion of patients
who complete treatment at nine months. We estimate
that 75% of control subjects will have completed cancer
treatment at 9 months. Based on our original projection
of 200 enrolled cancer patients, we have 80% power to
detect a difference in treatment completion rates of as
little as 16% between the navigated and standard care
patients. With 300 enrolled cancer patients, this detect-
able difference improves to 13%. These detectable effect
sizes are clinically meaningful. These estimates also
apply to any of the outcomes involving proportions such
as rates of patient adherence or receipt of guideline con-
cordant care.
Data Analysis
Continuous measures will be compared between rando-
mized groups, using two-sample t-tests. These measures
include times, mean satisfaction and quality of life
scores. Effect sizes are expressed in terms of standard
deviations of the measure given that we have no a priori
estimates of the distribution parameters. With the noted
sample sizes for cancer treatment subjects, the expected
sample will provide enough power to detect differences
in mean measures of as little as 0.4 standard deviations.
Cohen suggests that effect sizes of 0.2, 0.5 and 0.8 stan-
dard deviations can be considered “small”, “moderate”
and “large”. We expect to be able to detect moderately-
s m a l le f f e c t sw i t ht h i sa n a l y s i sa n ds h o u l dh a v ep o w e r
to detect clinically meaningful differences between the
groups.
At the conclusion of the trial, analysis will include
local as well as multi-institutional outcomes compari-
sons between intervention and control patients, combin-
ing data from multiple institutions performing trials of
patient navigation funded by the National Cancer Insti-
tute, under the multi-institutional granting structure.
Discussion
The elimination of health disparities is one of two over-
arching goals for Healthy People 2010[45]. Eliminating
disparities in cancer treatment has to date defied solu-
tion[8]. Patient navigation is among the few promising
methods for doing so. However, most PN programs lar-
gely focus on assisting patients with logistical barriers
and improving care coordination. In this paper, we
describe integration of this “traditional” PN with patient
activation through coaching. We outlined the steps we
have taken to implement the program as part of NCI’s
Patient Navigation Research Program.
Numerous patient navigation programs are currently
funded throughout the US, or in planning stages, often
with little theoretical or practical guidance on which to
base their designs and implementation. As cancer cen-
ters, foundations, and others throughout the US seek to
implement PN programs, the experiences described in
t h ep r e s e n ts t u d yw i l lb ev a l u a b l e .T h ec o n c e p t u a lf r a -
mework and training structures presented here are also
relevant to other medical conditions such as HIV,
chronic renal disease, or chronic pain among others,
that might benefit from PN.
During the design and implementation phase of this
trial, unanticipated challenges arose, requiring flexibility
to address them. First, the program was initially
designed to receive most referrals from the primary care
setting for abnormal screening follow-up. However, due
to changes in radiology centers’ protocols to more
directly handle abnormal screening follow-up them-
selves, navigation for screening was no longer needed in
our system. We therefore shifted PN activities to focus
on cancer patients, and redirected recruitment to the
community’s cancer centers.
Another key challenge has been learning how to effec-
tively navigate very high need patients. When patients’
financial and social needs exceeded what the program
could realistically provide, navigators learned to set lim-
its, particularly when patient requests went beyond help-
ing with cancer-care-related needs. Another challenge
has been in recruitment and retention of stable and
highly motivated CHW’s for patient navigation. Two
PNs have left the program and recruitment and training
can be time consuming. Our group has concluded that
close supervision of patient navigators with group dis-
cussion of cases is the key to providing effective support
for PNs.
The patient activation component of this intervention
is unique and is also one of the more difficult tasks con-
fronting the PNs, who seek to empower patients without
straining the relationship with cancer care providers.
The extensive training program has equipped them to
tackle this challenge, and patient and informal provider
feedback has been positive. The formal evaluation of
patient satisfaction and quality of life will occur at the
end of the study, along with measurements of guideline-
concordant care and time to completion of care. We
hypothesize that these parameters will be improved
compared to patients receiving standard care.
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grams in the US, objective success of PN in reducing
cancer health disparities remains unproven[46]. The
program described here and the overall NCI-PNRP
initiative seeks to answer the question: will the invest-
ment in PN pay dividends in measurable patient out-
comes? The results of our randomized, controlled trial
will attempt to show if care quality, timeliness and satis-
faction are improved by this intervention, and whether
racial or ethnic disparities in these measures are
reduced.
In conclusion, patient navigation and patient activation
can be combined into a single intervention to promote
optimal cancer care for underserved patients. Carefully
selected, non-medically-trained CHW’s can be trained to
assist patients and coach them to communicate more
effectively with their physicians, although close supervi-
sion is essential. If results of the randomized trial indicate
a benefit of this combined intervention on timeliness,
guideline concordance, patient satisfaction, and/or other
important outcomes, this program can serve as a model
for future PN program design.
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